Tilray Brands, Inc. (TLRY)

Market Cap	1.14B
Revenue (ttm)	830.77M
Net Income (ttm)	-2.15B
Shares Out	115.68M
EPS (ttm)	-23.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,724,762
Open	10.20
Previous Close	10.42
Day's Range	9.85 - 10.38
52-Week Range	3.51 - 23.20
Beta	2.13
Analysts	Buy
Price Target	150.00 (+1,419.76%)
Earnings Date	Jan 8, 2026

About TLRY

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the c...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Jul 19, 2018
• Employees: 2,842
• Stock Exchange: NASDAQ
• Ticker Symbol: TLRY
• Website: https://www.tilray.com

Financial Performance

In 2025, Tilray Brands's revenue was $821.31 million, an increase of 4.10% compared to the previous year's $788.94 million. Losses were -$2.19 billion, 792.6% more than in 2024.

Analyst Summary

According to 3 analysts, the average rating for TLRY stock is "Buy." The 12-month stock price target is $150.0, which is an increase of 1,419.76% from the latest price.

Price Target

$150.0

(1,419.76% upside)

Analyst Consensus: Buy